Related Experiment Videos
Mitral valve prolapse syndrome: neuro-endocrinological aspects
1Division of Cardiology, Ohio State University.
Herz
|August 1, 1988
Summary
Mitral valve prolapse (MVP) classification distinguishes between primary valvular issues and MVP syndrome, which involves neuroendocrine and autonomic dysfunction causing diverse symptoms.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Classification
Background:
- Mitral Valve Prolapse (MVP) affects numerous patients, often presenting with complex symptoms.
- Existing classifications may not fully address the diverse symptomatology in MVP patients.
- Understanding the underlying mechanisms is crucial for improved patient management.
Purpose of the Study:
- To develop a clinical classification for mitral valve prolapse (MVP).
- To differentiate between symptoms directly from valvular dysfunction and those related to MVP syndrome.
- To enhance understanding of the mechanisms contributing to MVP symptoms.
Main Methods:
- Analysis of 399 symptomatic patients with mitral valve prolapse (MVP).
- Review of reported clinical experiences with MVP patients.
- Development of a two-part clinical classification: anatomic MVP and MVP syndrome.
Main Results:
- Anatomic MVP: Symptoms/complications directly linked to valvular dysfunction.
- MVP syndrome: Symptoms not solely explained by valvular dysfunction, involving neuroendocrine/autonomic dysfunction.
- MVP syndrome symptoms include chest pain, palpitations, arrhythmias, orthostatic issues, fatigue, dyspnea, and neuropsychiatric complaints.
Conclusions:
- The proposed classification improves nosology and identification of MVP patients.
- MVP syndrome involves a complex interplay of neuroendocrine, autonomic, cardiac, renal, and adrenal factors.
- This "neuro-endocrine cardiovascular process" explains symptoms not attributable to valvular abnormality alone.